AAAAAA

   
Results: 1-15 |
Results: 15
DETERMINATION OF PILOCARPINE, ISOPILOCARPINE, PILOCARPIC ACID AND ISOPILOCARPIC ACID IN HUMAN PLASMA AND URINE BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH TANDEM MASS-SPECTROMETRIC DETECTION
Authors: VANDEMERBEL NC TINKE AP OOSTERHUIS B JONKMAN JHG BOHLE JF
Citation: Nc. Vandemerbel et al., DETERMINATION OF PILOCARPINE, ISOPILOCARPINE, PILOCARPIC ACID AND ISOPILOCARPIC ACID IN HUMAN PLASMA AND URINE BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH TANDEM MASS-SPECTROMETRIC DETECTION, Journal of chromatography B. Biomedical sciences and applications, 708(1-2), 1998, pp. 103-112
VALIDATED METHOD FOR THE DETERMINATION OF IDAZOXAN IN HUMAN PLASMA BYLIQUID-CHROMATOGRAPHY WITH TANDEM MASS-SPECTROMETRIC DETECTION
Authors: VANDEMERBEL NC TINKE AP VANDONGEN WD OOSTERHUIS B JONKMAN JHG LADURE P PUOZZO C
Citation: Nc. Vandemerbel et al., VALIDATED METHOD FOR THE DETERMINATION OF IDAZOXAN IN HUMAN PLASMA BYLIQUID-CHROMATOGRAPHY WITH TANDEM MASS-SPECTROMETRIC DETECTION, Journal of chromatography B. Biomedical sciences and applications, 708(1-2), 1998, pp. 113-120
A STUDY COMPARING BIOPHARMACEUTIC CHARACTERISTICS OF 4 ONCE-DAILY CONTROLLED-RELEASE DILTIAZEM PREPARATIONS
Authors: HENDRIKS MGC DOGTEROM P EBELS JT OOSTERHUIS B GEERTSEMA LR HULOT T BIANCHETTI G JONKMAN JHG
Citation: Mgc. Hendriks et al., A STUDY COMPARING BIOPHARMACEUTIC CHARACTERISTICS OF 4 ONCE-DAILY CONTROLLED-RELEASE DILTIAZEM PREPARATIONS, Fundamental and clinical pharmacology, 12(5), 1998, pp. 559-565
PHARMACOKINETICS OF [C-14]-LABELED LOSIGAMONE AND ENANTIOMERS AFTER ORAL-ADMINISTRATION TO HEALTHY-SUBJECTS
Authors: PEETERS PAM VANLIER JJ VANDEMERBEL N OOSTERHUIS B WIELING J JONKMAN JHG KLESSING K BIBER A
Citation: Pam. Peeters et al., PHARMACOKINETICS OF [C-14]-LABELED LOSIGAMONE AND ENANTIOMERS AFTER ORAL-ADMINISTRATION TO HEALTHY-SUBJECTS, European journal of drug metabolism and pharmacokinetics, 23(1), 1998, pp. 45-53
DISTRIBUTION OF CYP2D6 AND CYP2C19 PHENOTYPES IN DUTCH MALE AND FEMALE VOLUNTEERS IN CLINICAL-PHARMACOLOGY STUDIES
Authors: WILFFERT B TAMMINGA WJ WEMER J OOSTERHUIS B WIELING J JONKMAN JHG DELEY LFMH DEZEEUW RA
Citation: B. Wilffert et al., DISTRIBUTION OF CYP2D6 AND CYP2C19 PHENOTYPES IN DUTCH MALE AND FEMALE VOLUNTEERS IN CLINICAL-PHARMACOLOGY STUDIES, Naunyn-Schmiedeberg's archives of pharmacology, 357(4), 1998, pp. 690-690
LC PHASES IMPROVE, BUT NOT ALL ASSAYS DO - METFORMIN BIOANALYSIS REVISITED
Authors: VANDEMERBEL NC WILKENS G FOWLES S OOSTERHUIS B JONKMAN JHG
Citation: Nc. Vandemerbel et al., LC PHASES IMPROVE, BUT NOT ALL ASSAYS DO - METFORMIN BIOANALYSIS REVISITED, Chromatographia, 47(9-10), 1998, pp. 542-546
RATIONAL EXPERIMENTAL-DESIGN FOR BIOANALYTICAL METHODS VALIDATION - ILLUSTRATION USING AN ASSAY-METHOD FOR TOTAL CAPTOPRIL IN PLASMA
Authors: WIELING J HENDRIKS G TAMMINGA WJ HEMPENIUS J MENSINK CK OOSTERHUIS B JONKMAN JHG
Citation: J. Wieling et al., RATIONAL EXPERIMENTAL-DESIGN FOR BIOANALYTICAL METHODS VALIDATION - ILLUSTRATION USING AN ASSAY-METHOD FOR TOTAL CAPTOPRIL IN PLASMA, Journal of chromatography, 730(1-2), 1996, pp. 381-394
BIOPHARMACEUTIC CHARACTERISTICS OF A NEW EXTENDED-RELEASE THEOPHYLLINE FORMULATION (UNI-DUR)
Authors: OOSTERHUIS B BRANNAN MD GROEN H PEETERS PAM HEMPENIUS J RADWANSKI E NOMEIR AA AFFRIME MB JONKMAN JHG
Citation: B. Oosterhuis et al., BIOPHARMACEUTIC CHARACTERISTICS OF A NEW EXTENDED-RELEASE THEOPHYLLINE FORMULATION (UNI-DUR), Annals of allergy, asthma, & immunology, 75(2), 1995, pp. 157-161
THE PHARMACOKINETICS OF 3 MULTIPLE-DOSE REGIMENS OF CHLOROQUINE - IMPLICATIONS FOR MALARIA CHEMOPROPHYLAXIS
Authors: WETSTEYN JCFM DEVRIES PJ OOSTERHUIS B VANBOXTEL CJ
Citation: Jcfm. Wetsteyn et al., THE PHARMACOKINETICS OF 3 MULTIPLE-DOSE REGIMENS OF CHLOROQUINE - IMPLICATIONS FOR MALARIA CHEMOPROPHYLAXIS, British journal of clinical pharmacology, 39(6), 1995, pp. 696-699
LACK OF PHARMACOKINETIC INTERACTION BETWEEN VINPOCETINE AND OXAZEPAM
Authors: STORM G OOSTERHUIS B SOLLIE FAE VISSCHER HW SOMMER W BEITINGER H JONKMAN JHG
Citation: G. Storm et al., LACK OF PHARMACOKINETIC INTERACTION BETWEEN VINPOCETINE AND OXAZEPAM, British journal of clinical pharmacology, 38(2), 1994, pp. 143-146
HEMODYNAMIC-EFFECTS OF THE NEW ANTIARRHYTHMIC AGENT RESTACORIN IN PATIENTS WITH NORMAL AND DECREASED LEFT-VENTRICULAR FUNCTION
Authors: TUININGA YS CRIJNS HJGM OOSTERHUIS B WIESFELD ACP VANWIJK TM ALBRONDA F DEBRUIN ID JONKMAN JHG KOZMA C LIE KI
Citation: Ys. Tuininga et al., HEMODYNAMIC-EFFECTS OF THE NEW ANTIARRHYTHMIC AGENT RESTACORIN IN PATIENTS WITH NORMAL AND DECREASED LEFT-VENTRICULAR FUNCTION, Journal of cardiovascular pharmacology, 23(3), 1994, pp. 408-414
SINGLE-DOSE PHARMACOKINETICS OF CHLOROQUINE AND ITS MAIN METABOLITE IN HEALTHY-VOLUNTEERS
Authors: DEVRIES PJ OOSTERHUIS B VANBOXTEL CJ
Citation: Pj. Devries et al., SINGLE-DOSE PHARMACOKINETICS OF CHLOROQUINE AND ITS MAIN METABOLITE IN HEALTHY-VOLUNTEERS, Drug investigation, 8(3), 1994, pp. 143-149
EFFECT OF DIET ON THE SINGLE-DOSE AND MULTIPLE-DOSE PHARMACOKINETICS OF SUSTAINED-RELEASE KETOPROFEN
Authors: LELIBOUX A TEULE M FRYDMAN A OOSTERHUIS B JONKMAN JHG
Citation: A. Leliboux et al., EFFECT OF DIET ON THE SINGLE-DOSE AND MULTIPLE-DOSE PHARMACOKINETICS OF SUSTAINED-RELEASE KETOPROFEN, European Journal of Clinical Pharmacology, 47(4), 1994, pp. 361-366
PHARMACOKINETIC STUDIES IN HEALTHY-VOLUNTEERS IN THE CONTEXT OF INVITRO INVIVO CORRELATIONS
Authors: OOSTERHUIS B JONKMAN JHG
Citation: B. Oosterhuis et Jhg. Jonkman, PHARMACOKINETIC STUDIES IN HEALTHY-VOLUNTEERS IN THE CONTEXT OF INVITRO INVIVO CORRELATIONS, European journal of drug metabolism and pharmacokinetics, 18(1), 1993, pp. 19-30
ADVANTAGES AND DISADVANTAGES OF REFORMULATION OF OLDER DRUGS
Authors: OOSTERHUIS B JONKMAN JHG
Citation: B. Oosterhuis et Jhg. Jonkman, ADVANTAGES AND DISADVANTAGES OF REFORMULATION OF OLDER DRUGS, Clinical pharmacokinetics, 25(3), 1993, pp. 165-171
Risultati: 1-15 |